QRCode



Traders/Users: Online

2017/07/15

Biopharma stocks: 3 Undervalued Small-caps

By Jorge Aura

All investors know the risks of biotechnology companies. The strong volatility of these companies makes their prices fluctuate in excess. This sector has the peculiarity that offers a high risk but with a possible high gain. Identify pharmaceutical companies that have bottomed out or that are undervalued can be a good investment strategy for medium-term and short-term. In the following table will be able to see the readers, 3 companies which have greatly reduced their quoted prices since on January 6, 2017.

CompanyJanuary 6, 2017  July 7, 2017        
Galena Biopharma Inc $2.07  $0.55
Repros Therapeutics Inc$1.36  $0.50
Navidea Biopharmaceuticals Inc$0.625  $0.49

As you have seen in the upper table these companies have been hit hard during July, 2017. To determine if these companies are undervalued I have made a fundamental analysis of each company.

Galena Biopharma Inc (NASDAQ: GALE) is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets.
Source: Google finance

Galena lead product candidate is GALE-401. This product contains the active ingredient anagrelide, an FDA-approved product, for the treatment of patients with myeloproliferative neoplasms ("MPNs") to lower abnormally elevated platelet levels. The currently available immediate release ("IR") version of anagrelide causes adverse events that are believed to be dose and plasma concentration dependent, and may limit the use of the IR version of the drug. Therefore, reducing the maximum concentration ("Cmax") and increasing the half-life of the drug is hypothesized to reduce the side effects, while preserving the efficacy, potentially allowing a broader use of the drug.
Source: Galena Biopharma Inc

Galena Biopharma has a market cap of $21.18 million. Its trailing P/E is 2.51. It has a total cash position on its balance sheet of just $42.046,Million. The company announced a revenue on three months ended March 31 of $0.


             Source: Stockcharts.com

This stock plunged from its high of $4.75 to a recent low of $0.16. If you are bullish on this stock, I would look to be a buyer on the next high-volume move above some near-term overhead resistance at $0.58 a share. Look for volume that's tracking in close to or above its three-month average action of 599,062 shares. Keep in mind that the company has approved the possibility of performing a reverse split recently.

Repros Therapeutics Inc (NASDAQ: RPRX) is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. The Company's product candidates include enclomiphene, which is a single isomer of clomiphene citrate, an orally active small molecule compound, and Proellex, which is an orally administered selective blocker of the progesterone receptor in women, for the treatment of uterine fibroids and endometriosis.
Source: Google finance

Repros Therapeutics has a market cap of $16.98 million. Its trailing P/E is incalculable and its forward P/E is just incalculable as the majority of pharmaceutical companies of small-capitalization.  It has a total cash position on its balance sheet of just $3.23 Million. The company announced a revenue on three months ended March 31 of $0.


           Source: Stockcharts.com

This stock plunged from its high of $2.48 to a recent low of $0.33. If you are bullish on this stock, I would look to be a buyer on the next high-volume move above some near-term overhead resistance at $0.58 a share. Look for volume that's tracking in close to or above its three-month average action of 905,240 shares.

Navidea Biopharmaceuticals Inc (NYSEAMEX: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on the Manocept platform to help identify the sites and pathways of undetected disease.
Source: Google finance

Navidea has a market cap of $78.10 Million. Its trailing P/E is incalculable and its forward P/E is just incalculable as the majority of pharmaceutical companies of small-capitalization. It has a total cash position on its balance sheet of just $13.44 Million. The company announced a revenue on three months ended March 31 of $580,000.

           Source: Stockcharts.com

This stock plunged from its high of $1.16 to a recent low of $0.26. If you are bullish on this stock, I would look to be a buyer on the next high-volume move above some near-term overhead resistance at $0.50 a share. Look for volume that's tracking in close to or above its three-month average action of 386,176 shares.

Disclosure: Jorge Aura has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. Jorge Aura wrote this article himself, and it expresses his own opinions. He is not receiving compensation for it.  Jorge Aura has no business relationship with any company whose stock is mentioned in this article.

15 comentarios:

The post is truly great, I appreciate your intention to explain all issues you've encountered with! Knowing the risks of biotechnology companies, we can simply set up particular strategies to avoid different issues.

This is an excellent article. For me, this is a fascinating topic. This website offers numerous advantages. This website gave me a lot of useful information. It helps me in a number of ways. Thank you very much for making this information available.

When faced with a difficult case study solver, many students turn to the internet for help. There are a number of online resources that offer case study solutions, but not all of them are reliable. It is important to carefully research any site before using its services.

Many students don't know where to go for finance assignment helper. We provide finance assignment help with expert writers who are qualified to write on any finance topic.

Engaging in investments with undervalued pharmaceutical companies can present a challenging yet potentially lucrative approach, as evidenced by the table showcasing three enterprises that have encountered substantial decreases in their stock prices.Iam a professional academic content writer and I also offer an online
Professional Essay Writers to the students at a cheap rate.


Exploring biopharma stocks is like uncovering hidden treasures among small caps. These undervalued gems hold the potential for significant growth, much like navigating the diverse offerings in a tiger exchange.

These small-cap stocks, despite being undervalued, have significant potential for growth and profitability. Investing in biopharma stocks offers the chance to support innovative medical advancements while potentially yielding substantial returns on investment.

Orah Pharmacy, your one-stop destination for premium pharmaceutical care delivered right to your doorstep.

These printable coloring pages are a lifesaver! They keep my kids happily occupied and boost their creativity. Thanks for sharing such a fantastic resource!

Explore the nutritious and delicious low fat milk options available at Olpers Mart. Our low fat milk is perfect for those seeking a healthier lifestyle without compromising on taste. Packed with essential vitamins and minerals, it supports strong bones and overall well-being. Shop at Olpers Mart for the best low fat milk and experience the convenience of having it delivered right to your doorstep. Choose Olpers Mart for your daily dose of health and nutrition.

Welcome to Orah Pharmacy, your reliable online pharmacy destination in Pakistan. At Orah Pharmacy, we provide a wide range of medications, health products, and wellness essentials, all available at the click of a button. Our user-friendly website, orah.pk, ensures a seamless shopping experience, allowing you to conveniently order your prescriptions and health products online. With fast and secure delivery services, Orah Pharmacy is dedicated to making healthcare accessible and hassle-free for everyone. Experience the convenience and trust of an online pharmacy with Orah Pharmacy today.

Explore the finest quality cocoa powder at Baqa Foods, your reliable source for premium ingredients in Pakistan. We offer competitive cocoa powder prices, ensuring you get the best value for your money. Our cocoa powder is perfect for baking, cooking, and making delicious beverages. With a commitment to quality and customer satisfaction, Baqa Foods provides a seamless shopping experience with secure online transactions and prompt delivery. Visit baqafoods to check out our latest cocoa powder prices and enhance your culinary creations with the rich, delectable taste of Baqa Foods' cocoa powder.

Indulge in the essence of authenticity with our collection of original perfumes. Each fragrance is a masterpiece crafted with care, offering a unique olfactory journey that resonates with individuality.

Welcome to Rholab, your trusted hub for ecommerce distribution solutions tailored to propel your business to new heights.

Indulge in the luscious sweetness of caramel syrup, a velvety elixir that transforms any treat into a sumptuous delight.